Literature DB >> 8352433

Effect of dietary lipid on insulin action. Clinical studies.

B A Swinburn1.   

Abstract

Evidence from the best studies available in the literature suggest that the isocaloric substitution of dietary fat for dietary carbohydrate does not cause insulin resistance. Although many studies show several differences between the diets (for example, changes in dietary fiber or fat subtype), the diets were primarily designed to compare the effects of the fat/carbohydrate content, and a true important effect of dietary fat on insulin action should have been detected. Some studies found other changes in carbohydrate metabolism such as improvements in insulin secretion and glucose effectiveness (Sg) that could contribute to the conflicting results. For example, glucose uptake as measured by the euglycemic clamp includes both insulin-dependent and non-insulin-dependent (SG) factors, so that the M value could be affected by changes in SG as well as in insulin action. All of these studies have used isocaloric substitution so that body weight is maintained. This constraint, while important for determining and direct effect of dietary fat, may lead to false conclusions about its overall effects on insulin action. One of the most common and potent causes of insulin resistance is obesity, and dietary fat is of singular importance in the genesis of obesity. Inasmuch as an ad libitum reduced fat diet causes weight loss, the overall effect of dietary fat reduction may be an improvement in insulin action because of weight loss even in the absence of any direct effects. Long-term studies of the effects of fat content within ad libitum diets are needed to place these largely negative results from isocaloric studies in context.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8352433     DOI: 10.1111/j.1749-6632.1993.tb35697.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  The tsim tsoum approaches for prevention of cardiovascular disease.

Authors:  R B Singh; Fabien Demeester; Agnieska Wilczynska
Journal:  Cardiol Res Pract       Date:  2010-06-29       Impact factor: 1.866

2.  Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35.

Authors:  A L DePaula; A L V Macedo; N Rassi; C A Machado; V Schraibman; L Q Silva; A Halpern
Journal:  Surg Endosc       Date:  2008-03       Impact factor: 4.584

3.  Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20-34.

Authors:  Aureo Ludovico DePaula; A L V Macedo; V Schraibman; B R Mota; S Vencio
Journal:  Surg Endosc       Date:  2008-10-02       Impact factor: 4.584

4.  Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis.

Authors:  Rahul Sao; Wilbert S Aronow
Journal:  Arch Med Sci       Date:  2017-07-05       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.